ARPA-H, the government agency that funds cutting edge health research, plans to commit $62.7 million to develop artificial ...
In a pair of late-stage trials, an AstraZeneca drug reduced the dangerous flare-ups that worsen COPD, positioning it as a ...
Caspian Therapeutics, is launching with $50 million in financing to develop menin inhibitors for diabetes and other ...
The goal should not be to reproduce today’s health care system with fewer humans,” writes American Medical Association CEO ...
WASHINGTON — The Trump administration permanently filled four key leadership roles at the Food and Drug Administration on ...
CEOs of the biggest AI companies have predicted the technology will “eliminate most cancer” and “improve treatment of most ...
For the past few months, key centers at the FDA have been led by acting officials. The agency said yesterday it will now make them permanent. Michael Davis will be director of the Center for Drug ...
The CDC’s National Center for Immunization and Respiratory Diseases is undergoing a reorganization, with Covid-19 and other ...
Autonomous AI will likely soon exceed both unaided physicians and physicians aided by AI at five core cognitive medical tasks ...
The FDA warned a supplier of active pharma ingredients about residue on walls, a corroded product line, and open-toed sandals ...
A Novartis drug for a rare neuromuscular condition failed in a key study, the company's second major trial collapse in a ...
Katherine Clark, a top House Democrat, received more than $100,000 in campaign donations from people linked to UnitedHealth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results